Back to Search
Start Over
K3036.58 in the μ opioid (MOP) receptor is important in conferring selectivity for covalent binding of β-funaltrexamine (β-FNA)
- Source :
- European Journal of Pharmacology. 748:93-100
- Publication Year :
- 2015
- Publisher :
- Elsevier BV, 2015.
-
Abstract
- β-funaltrexamine (β-FNA) is an irreversible μ opioid (MOP) receptor antagonist and a reversible agonist of κ opioid (KOP) receptor. β-FNA binds covalently to the MOP receptor at Lys233 5.39 , which is conserved among opioid receptors. Molecular docking of β-FNA showed that K303 6.58 in the MOP receptor and E297 6.58 in the KOP receptor played distinct roles in positioning β-FNA. K303 6.58 E MOP receptor and E297 6.58 K KOP receptor mutants were generated. The mutations did not affect β-FNA affinity or efficacy. K303 6.58 E mutation in the MOP receptor greatly reduced covalent binding of [ 3 H]β-FNA; however, E297 6.58 K did not enable the KOP receptor to bind irreversibly to β-FNA. Molecular modeling demonstrated that the e-amino group of K303 6.58 in the MOP receptor interacted with C O of the acetate group of β-FNA to facilitate covalent bond formation with Lys233 5.39 . Replacement of K303 6.58 with Glu in the MOP receptor resulted in repulsion between the COOH of Glu and the C O of β-FNA and increased the distance between K233 5.39 and the fumarate group, making it impossible for covalent bond formation. These findings will be helpful for design of selective non-peptide MOP receptor antagonists.
- Subjects :
- Agonist
Molecular model
Protein Conformation
Stereochemistry
medicine.drug_class
Narcotic Antagonists
Receptors, Opioid, mu
κ-opioid receptor
Article
Substrate Specificity
Mice
Cell Line, Tumor
medicine
Animals
Humans
skin and connective tissue diseases
Receptor
Conserved Sequence
Pharmacology
Chemistry
Lysine
Receptors, Opioid, kappa
Receptor antagonist
Naltrexone
Rats
Molecular Docking Simulation
body regions
surgical procedures, operative
Opioid
Covalent bond
Mutation
μ-opioid receptor
Extracellular Space
Protein Binding
medicine.drug
Subjects
Details
- ISSN :
- 00142999
- Volume :
- 748
- Database :
- OpenAIRE
- Journal :
- European Journal of Pharmacology
- Accession number :
- edsair.doi.dedup.....7f443162a1be40a4d4c3af327449506c